Literature DB >> 2424212

Thyroid hormones in generalized scleroderma. A controlled study.

J Serup, H Hangdrup.   

Abstract

Parameters of thyroid metabolism were analysed in 42 patients with generalized scleroderma and healthy individuals matched with respect to sex and age for comparison. Decreased free thyroxine (p less than 0.01), decreased free triiodothyronine (p less than 0.001), and increased thyroid-stimulating hormone (p less than 0.001) evidenced an associated state of myxoedema in scleroderma. Total thyroxine was normal, and total triiodothyronine was increased (p less than 0.01) probably reflecting binding to abnormal serum proteins in scleroderma. Normal concentrations of reverse triiodothyronine indicated a normal peripheral metabolism of thyroid hormones. Thyroid-stimulating immunoglobulins also analysed were within normal range. Changes in free thyroxine, free triiodothyronine, and thyroid-stimulating hormone were quantitatively small with mean values within normal ranges. In conclusion, this study evidenced a mild associating myxoedema state in generalized scleroderma. Probably, this reflected slight and subclinical affection of the thyroid.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424212

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  6 in total

1.  Thyroid dysfunction in a prospectively followed series of patients with progressive systemic sclerosis.

Authors:  L De Keyser; D C Narhi; D E Furst; A K Huberman; R Ross; J Clements; A J Van Herle
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

2.  Frequency of biochemical hypothyroidism in sera referred for autoantibody testing.

Authors:  H Reyes; J B Peter
Journal:  Clin Diagn Lab Immunol       Date:  1994-05

Review 3.  Thyroid disorders in patients with progressive systemic sclerosis: a review.

Authors:  E J Kucharz
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

4.  Can thyroid volume predict thyroid dysfunction in patients with systemic sclerosis? A prospective cross-sectional study from a tertiary care center in North West India.

Authors:  Pawan Kumar Singh; Shefali Khanna Sharma; Anindita Sinha; Pinaki Dutta
Journal:  Clin Rheumatol       Date:  2016-02-09       Impact factor: 2.980

5.  Systemic sclerosis associated with generalized vasculitis and hypopituitarism.

Authors:  John C Katsantonis; John Protopsaltis; Stelios Kokkoris; Paris Brestas; Kyriaki Aroni; Symeon Tournis; Gregory Giannoulis
Journal:  Rheumatol Int       Date:  2008-04-24       Impact factor: 2.631

Review 6.  Associations between Systemic Sclerosis and Thyroid Diseases.

Authors:  Poupak Fallahi; Ilaria Ruffilli; Dilia Giuggioli; Michele Colaci; Silvia Martina Ferrari; Alessandro Antonelli; Clodoveo Ferri
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-03       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.